New adalimumab biosimilars prepare to launch in Canada, US and Europe

Biosimilars/News | Posted 16/05/2022 comments 0
Adalimumab V13F21

Several new adalimumab biosimilar products are preparing to launch in Canada, the US and Europe, from manufacturers including BIOJAMP, Alvotech and Celltrion.

More >
FORO LATINOAMERICANO DE ESTA SEMANA
Naming 3 V13J04
Nomenclature of biologicals and biocomparables in Mexico
Posted 18/03/2022

Following the articles on the management and implementation of the nomenclature of biol...

25 AA011049
COVID-19 vaccine produced in Latin America
Posted 18/03/2022

The World Health Organization (WHO) approved a COVID-19 vaccine produced in Latin Ameri...

INVIMA V22B11
Biosimilars approved in Colombia
Posted 11/02/2022

In Colombia, the regulatory body for the approval of biologicals is the National Food a...

Home/Non‐Biological Complex Drugs
Liposome V15L11

On 4 April 2018, the US Food and Drug Administration (FDA) issued a new draft guidance...

More >